Injection of G-CSF in patients affected by Crohn's disease increases IL-10-secreting T cells in peripheral blood and enhances accumulation of plasmacytoid DC in the lamina propria, resulting in clinical benefit 52. Here, IL10 is linked to Crohn disease.